New Minnesota law protects patients with chronic disease
Minnesota chronic pain patients will have increased access to the medications they need thanks to a new state law.
AMA urges governors to adopt DEA guidance for opioid use disorder
This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.
State policy changes that can help COVID-19 fight
States can’t allocate trillions the way Congress can. Learn what state policymakers can do in the battle against the COVID-19 pandemic.
Patient care for SUD, mental illness, chronic pain during COVID-19
The AMA provides guidance on caring for patients with substance use disorder, mental illness or chronic pain during the COVID-19 pandemic.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
AMA, APHA, ASHP issue joint statement about COVID-19 medications
The joint statement is in response to reports of physicians and others prophylactically prescribing, medications currently identified as potential treatments for COVID-19.
Joint statement on ordering, prescribing or dispensing COVID-19 medications
Organizations highlight role physicians, pharmacists and health systems play in being just stewards of health care resources during times of emergency.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights
COVID-19 action plan
This quick-start COVID-19 guide, curated from comprehensive CDC, JAMA Network and WHO resources, will help prepare your practice, address patient concerns and answer your most pressing questions.
Get Advocacy Update
The newsletter includes exclusive news on key national and state issues, a cutting-edge guide to physician advocacy and discounts on state and federal conferences.Subscribe Now